How real is intention-to-treat (ITT) analysis in non-interventional post authorization safety studies? We can do better

Current Drug Safety

Volumn 4, Issue 2, 2009, Pages 137-142

  Kiri, Victor A ^a,b   MacKenzie, Gilbert ^b  

^a PAREXEL INTERNATIONAL   (United States)

^b UNIVERSITY OF LIMERICK   (Ireland)

Author keywords

Case control design; Cohort study; Counter matching; Selection bias

Indexed keywords

CASE CONTROL STUDY; CASE STUDY; CLINICAL PROTOCOL; CLINICAL RESEARCH; COHORT ANALYSIS; DRUG SAFETY; HEALTH CARE PRACTICE; INFORMATION PROCESSING; METHODOLOGY; PHARMACOEPIDEMIOLOGY; PRIORITY JOURNAL; REVIEW; TIME SERIES ANALYSIS; ARTICLE; CLINICAL TRIAL; CROSSOVER PROCEDURE; DRUG TOXICITY; EPIDEMIOLOGY; HUMAN; POSTMARKETING SURVEILLANCE; RISK; STATISTICAL ANALYSIS; STATISTICAL MODEL; TIME;

BIAS (EPIDEMIOLOGY); CASE-CONTROL STUDIES; CLINICAL TRIALS AS TOPIC; COHORT STUDIES; CROSS-OVER STUDIES; DATA INTERPRETATION, STATISTICAL; DRUG TOXICITY; EPIDEMIOLOGIC METHODS; HUMANS; MODELS, STATISTICAL; ODDS RATIO; PRODUCT SURVEILLANCE, POSTMARKETING; RESEARCH DESIGN; TIME FACTORS;

EID: 67849092760     PISSN: 15748863     EISSN: None     Source Type: Journal    
DOI: 10.2174/157488609788173008     Document Type: Review

References (41)

1. Miettenen OS, Caro JJ. Principles of nonexperimental assessment of excess risk, with special reference to adverse drug reactions. J Clin Epidemiol 1989; 42(4): 325-31.
2. Guess HA. Behavior of the exposure odds ratio in a case-control study when the hazard function is not constant over time. J Clin Epidemiol 1989; 42(12): 1179-84.
3. Suissa S. Novel approaches to pharmacoepidemiology study design and statistical analysis. In: Strom BL, Ed. Pharmacoepidemiology, 3rd ed. New York: John Wiley & Sons 2000; pp. 785-805.
4. Black C, Kaye JA, Jick H. Relation of childhood gastrointestinal disorders to autism: nested case-control study using data from the UK general practice research database. BMJ 2002; 325(7361): 419-21.
5. Eland IA, Huerta-Alvarez C, Stricker B, et al. The risk of acute pancreatitis associated with acid-suppressing drugs. Br J Clin Pharmacol 2000; 49: 473-8.
6. Nightingale AL, Farmer RD. Ischemic stroke in young women: a nested case-control study using the UK general practice research database. Stroke 2004; 35: 1574-8.
7. Clayton D, Hill M. Statistical Models in Epidemiology. Oxford: Oxford University Press 1993.
8. Greenland S, Neutra R. Control of confounding in the assessment of medical technology. Int J Epidemiol 1980; 9(4): 361-7.
9. Horwitz RI, McFarlane MJ, Brennan TA, Feinstein AR. The role of susceptibility bias in epidemiologic research. Arch Intern Med 1985; 145(5): 909-912.
10. Petri H, Urquhart J. Channelling bias in the interpretation of drug effects. Stat Med 1991; 10: 577-81.
11. Rosenbaum P, Rubin DR. The central role of propensity score in observational studies for casual effects. Biometrika 1983; 70(1): 41-55.
12. D'Agostino RB. Tutorial in biostatistics- Propensity score methods for bias reduction in the comparison of a treatment to a non-randomized control group. Stat Med 1998; 17: 2265-81.
13. Morant SV, Pettitt D, MacDonald TM, et al. Application of propensity score to adjust for channelling bias with NSAIDs. Pharmacoepidemiol Drug Saf 2004; 13: 345-53.
14. Frolkis JP, Pthier CE, Blackstone EH, et al. Frequent ventricular ectopy after exercise as a predictor of death. N Engl J Med 2003; 348-9.
15. Heckman JJ. Sample Selection Bias as a Specification Error. Econometrica 1979; 47(1): 153-61.
16. Crown WH, Obenchain RL, Englehart L, et al. The application of sample selection models to outcomes research: the case of evaluating the effects of antidepressants therapy on resource utilization. Stat Med 1998; 17:1943-58.
17. Sartori AE. An estimator for some binary-outcome selection models without exclusion restrictions. Polit Anal 2003; 11: 111-38.
18. Christopher W, Mare RD. Models for sample selection bias. Annu Rev Sociol 1992; 18: 327-50.
19. Maclure M. The case cross-over design: a method for studying transient effects on the risk of acute events. Am J Epidemiol 1991; 133: 144-53.
20. Warner L, Macaluso M, Austin HD, et al. Application of the case-crossover design to reduce unmeasured confounding in studies of condom effectiveness. Am J Epidemiol 2005; 161: 765-73.
21. Hernandez-Diaz S, Hernán MA, Meyer K, et al. Case cross-over and case-time-control designs in birth defects epidemiology. Am J Epidemiol 2003; 158: 385-91.
22. Marshall RJ, Jackson RT. Analysis of case-crossover designs. Stat Med 1993; 12: 2333-41.
23. Park T, Ki M, Yi SG. Statistical analysis of MMR vaccines adverse events on aseptic meningitis using the case cross-over design. Stat Med 2004; 23(12): 1871-83.
24. Suissa S. The case-time-control design. Epidemiology 1995; 6: 248-253.
25. Suissa S. The case-time-control design: further assumptions and conditions. Epidemiology 1998; 9: 441-5.
26. Greenland S. Confounding and exposure trends in case-crossover and case-time-control designs. Epidemiology 1996; 7: 231-9.
27. Donnan PT, Wang J. The case-crossover and case-time-control designs. Pharmacoepidemiol Drug Saf 2001; 10(3): 259-62.
28. Schneider M, Gange SJ, Margolick JB, et al. Application of case cross-over and case-time-control study designs in analysis of time varying predictors of T-cell homeostasis failure. Ann Epidemiol 2005; 15(2): 137-44.
29. Feldmann U. Epidemiologic assessment of risks of adverse reactions associated with intermittent exposure. Biometrics 1993; 49: 419-28.
30. Farrington CP, Nash J, Miller E. Case series analysis of adverse reactions to vaccines: a comparative evaluation. Am J Epidemiol 1996; 143: 1165-73. [Erratum, Am J Epidemiol 1998; 147: 93].
31. Farrington CP. Relative incidence estimation from case series for vaccine safety evaluation. Biometrics 1995; 51: 228-35.
32. Smeeth L, Thomas SL, Hall AJ, et al. Risk of Myocardial Infarction and Stroke after Acute Infection or Vaccination. N Engl J Med 2004; 351: 2611-8.
33. Prentice RL. A case-cohort design for epidemiolgic cohort studies and disease prevention trials. Biometrika 1986; 73:1-11.
34. Barlow WE. Robust variance estimation for the case-cohort design. Biometrics 1994; 50: 1064-72.
35. Barlow WE, Ichikawa L, Rosner D, Izumu S. Analysis of case-cohort designs. J Clin Epidemiol 1999; 52(12): 1165-72.
36. Cox D. Partial likelihood. Biometrika 1975; 62: 265-76.
37. Cox DR, Oakes D. Analysis of survival data. Monographs on Statistics and Applied Probability. New York: Chapman and Hall; 1984.
38. Besag J. Efficiency of Pseudolikelihood estimation for simple Gaussian fields. Biometrika 1977; 64: 616-8.
39. Sato T. Estimation of a common risk ratio in stratified case-cohort studies. Stat Med 1992; 11: 1599-605.
40. Reid N, Crepeau H. Influence functions for proportional hazards regression. Biometrika 1985; 72: 1-9.
41. Lin DY, Wei LJ. The robust inference for the Cox-proportional hazards model. J Acoust Soc Am 1989; 84: 1074-78.